Longitudinal analysis explores cognitive decline and brain atrophy in relation to plasma biomarkers and APOE-ε4, indicating potential predictive value.
ADAMTS13 shows promise as a potential plasma biomarker for brain aging outcomes, but additional research is warranted to understand the performance of VWF in the presence versus absence of an APOE-ε4 allele.
No takes yet. Share an insight, caveat, or question.
Adegboye et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: